Exhibit 99.2
UNAUDITED PROFORMA COMBINED CONSOLIDATED FINANCIAL STATEMENTS
On April 20, 2020, Omnia Wellness Inc. (formerly known as Glolex Inc.), entered into a Share Exchange and Reorganization Agreement (the “Exchange Agreement”) with Omnia Wellness Corporation (formerly known as Bed Therapies, Inc.) (“OWC”) and the beneficial stockholders of OWC to acquire 100% of the issued and outstanding shares of capital stock of OWC. The transactions contemplated by the Exchange Agreement were consummated on December 31, 2020 and, pursuant to the terms of the Exchange Agreement, among other things, all outstanding shares of common stock of OWC, no par value, or the OWC Shares, were exchanged for shares of our common stock, par value $0.001 per share, based on the Exchange Ratio of one share of our common stock for every one OWC Share. We refer herein to the transactions contemplated by the Exchange Agreement, collectively, as the Acquisition. Accordingly, we acquired 100% of OWC in exchange for the issuance of shares of our common stock and OWC became our wholly-owned subsidiary. As of the closing of the Acquisition (the “Closing”), Mr. Amer Samad, the former sole director and executive officer of Omnia Wellness Inc., agreed to cancel 52,656,888 shares of our common stock as part of the conditions to Closing, which are expected to be cancelled as soon as practicable after Closing.
At the Closing, in connection with the Acquisition, an aggregate of approximately $539,968 principal amount of convertible promissory notes of Omnia Corp. converted in accordance with their terms into an aggregate of 1,269,665 shares of our common stock. Of such shares, 729,730 were issued to Nickolay Kukekov, a director, and 539,935 were issued to M. Jainal Bhuiyan, a director and executive officer, or their respective affiliates as the holders of such notes.
The unaudited pro forma combined financial statements presented below are prepared using recapitalization accounting for the Reverse Merger. Pro forma adjustments which give effect to certain transactions occurring as a direct result of the Reverse Merger are described in the accompanying unaudited notes presented on the following pages.
The unaudited pro forma combined balance sheet is prepared as though the Reverse Merger occurred at the close of business on September 30, 2020. The unaudited pro forma combined statements of comprehensive loss give effect to the Reverse Merger as though it occurred on January 1, 2019. OWC’s fiscal year end is December 31. Omnia Wellness’ fiscal year end is March 31. The statements of comprehensive loss for Omnia Wellness are presented for the nine months ended September 30, 2020, and for the year ended December 31, 2019 to conform to the Company’s fiscal year end of December 31.
The unaudited pro forma combined financial statements have been prepared for illustrative purposes only and are not necessarily indicative of the consolidated financial position or results of operations in future periods or the results that actually would have been realized had the Company and OWC been a combined company during the specified periods. The unaudited pro forma combined financial statements, including the notes thereto, are qualified in their entirety by reference to, and should be read in conjunction with, the historical financial statements of OWC included herein and the historical financial statements of the Company included in its Annual Report on Form 10-K for the fiscal year ended March 31, 2020 as filed with the United States Securities and Exchange Commission (“SEC”) on July 14, 2020 and in its Quarterly Report on Form 10-Q for the six months ended September 30, 2020 as filed with the SEC on November 16, 2020.
Omnia Wellness, Inc.
Pro Forma Combined Consolidated Balance Sheet
(Unaudited)
| | Omni Wellness, Inc. | | | Omnia Wellness Corporation | | | | | | | | Pro-Forma Combined | |
| | September 30, 2020 | | | September 30, 2020 | | | Pro-Forma Adjustments | | | Adj # | | September 30, 2019 | |
| | | | | | | | | | | | | | |
Assets | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | |
Current assets | | | | | | | | | | | | | | | | | | |
Due from related parties | | $ | - | | | $ | 84,920 | | | $ | - | | | | | $ | 84,920 | |
Advance payments on purchase of inventory, related party | | | - | | | | 18,000 | | | | - | | | | | | 18,000 | |
Total current assets | | | - | | | | 102,920 | | | | - | | | | | | 102,920 | |
| | | | | | | | | | | | | | | | | | |
Non-current assets | | | | | | | | | | | | | | | | | | |
Fixed assets, net | | | - | | | | 336,990 | | | | - | | | | | | 336,990 | |
Intangible assets related party, net | | | - | | | | 1,701,000 | | | | - | | | | | | 1,701,000 | |
Total non-current assets | | | - | | | | 2,037,990 | | | | - | | | | | | 2,037,990 | |
| | | | | | | | | | | | | | | | | | |
Total Assets | | $ | - | | | $ | 2,140,910 | | | $ | - | | | | | $ | 2,140,910 | |
| | | | | | | | | | | | | | | | | | |
Liabilities and Stockholders’ Deficit | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | |
Current liabilities: | | | | | | | | | | | | | | | | | | |
Accounts payable and accrued expenses | | $ | 49,353 | | | $ | 27,790 | | | $ | - | | | | | $ | 77,143 | |
Accounts payable, related party | | | - | | | | 435,921 | | | | - | | | | | | 435,921 | |
Deposit liability | | | - | | | | 73,438 | | | | - | | | | | | 73,438 | |
Accrued interest | | | - | | | | 526,260 | | | | (39,998 | ) | | C | | | 486,262 | |
Warranty liability | | | - | | | | 21,469 | | | | - | | | | | | 21,469 | |
Nonconvertible notes, related party | | | 10,618 | | | | 753,140 | | | | - | | | | | | 763,758 | |
Nonconvertible notes, non related | | | - | | | | 1,590,000 | | | | - | | | | | | 1,590,000 | |
Convertible notes, related party | | | - | | | | 583,940 | | | | (499,970 | ) | | C | | | 83,970 | |
Convertible notes, non related | | | 12,000 | | | | 1,750,000 | | | | - | | | | | | 1,762,000 | |
Total current liabilities | | | 71,971 | | | | 5,761,958 | | | | (539,968 | ) | | | | | 5,293,961 | |
| | | | | | | | | | | | | | | | | | |
Non-current liabilities: | | | | | | | | | | | | | | | | | | |
PPP Loan | | | - | | | | 294,066 | | | | - | | | | | | 294,066 | |
Nonconvertible notes, non related, less current | | | - | | | | 156,620 | | | | - | | | | | | 156,620 | |
Convertible notes, non related, less current | | | - | | | | 150,000 | | | | - | | | | | | 150,000 | |
Total non-current liabilities | | | - | | | | 600,686 | | | | - | | | | | | 600,686 | |
| | | | | | | | | | | | | | | | | | |
Total Liabilities | | | 71,971 | | | | 6,362,644 | | | | (539,968 | ) | | | | | 5,894,647 | |
| | | | | | | | | | | | | | | | | | |
Stockholders’ deficit: | | | | | | | | | | | | | | | | | | |
Preferred stock | | | - | | | | - | | | | - | | | | | | - | |
Common stock | | | 55,058 | | | | - | | | | (41,387 | ) | | A, B | | | 13,671 | |
Additional paid-in capital | | | (10,224 | ) | | | - | | | | 464,550 | | | A, B, C | | | 454,326 | |
Accumulated deficit | | | (116,805 | ) | | | (4,221,734 | ) | | | 116,805 | | | A, B | | | (4,221,734 | ) |
Total stockholders’ deficit | | | (71,971 | ) | | | (4,221,734 | ) | | | 539,968 | | | | | | (3,753,737 | ) |
| | | | | | | | | | | | | | | | | | |
Total Liabilities and Stockholders’ Deficit | | $ | - | | | $ | 2,140,910 | | | $ | - | | | | | $ | 2,140,910 | |
Omnia Wellness, Inc.
Pro Forma Combined Consolidated Statements of Operations
For the nine months ended September 30, 2020
(Unaudited)
| | Omnia Wellness, Inc | | | Omnia Wellness Corporation | | | Pro Forma Adjustments | | | Adj # | | Pro Forma Combined | |
| | | | | | | | | | | | | | |
Revenue | | | | | | | | | | | | | | | | | | |
Sales | | $ | - | | | $ | 168,787 | | | $ | - | | | | | $ | 168,787 | |
Total Revenues | | | - | | | | 168,787 | | | | - | | | | | | 168,787 | |
| | | | | | | | | | | | | | | | | | |
Cost of goods sold | | | | | | | | | | | | | | | | | | |
Cost of goods sold | | | - | | | | 97,537 | | | | - | | | | | | 97,537 | |
Total cost of goods sold | | | - | | | | 97,537 | | | | - | | | | | | 97,537 | |
Gross profit | | | - | | | | 71,250 | | | | - | | | | | | 71,250 | |
| | | | | | | | | | | | | | | | | | |
Operating expenses | | | | | | | | | | | | | | | | | | |
Warranty expense | | | - | | | | 9,201 | | | | - | | | | | | 9,201 | |
Depreciation and amortization | | | - | | | | 207,340 | | | | - | | | | | | 207,340 | |
Legal and professional fees | | | - | | | | 74,028 | | | | - | | | | | | 74,028 | |
Payroll expense | | | - | | | | 237,483 | | | | - | | | | | | 237,483 | |
Selling and marketing expense | | | - | | | | 80,638 | | | | - | | | | | | 80,638 | |
Selling and marketing expense, related party | | | - | | | | 112,500 | | | | - | | | | | | 112,500 | |
Consulting fees | | | - | | | | 139,091 | | | | - | | | | | | 139,091 | |
General and administrative | | | 45,280 | | | | 217,465 | | | | - | | | | | | 262,745 | |
Total operating expenses | | | 45,280 | | | | 1,077,746 | | | | - | | | | | | 1,123,026 | |
| | | | | | | | | | | | | | | | | | |
Other expense | | | | | | | | | | | | | | | | | | |
Interest expense | | | - | | | | (381,419 | ) | | | - | | | | | | (381,419 | ) |
Total other expense | | | - | | | | (381,419 | ) | | | - | | | | | | (381,419 | ) |
| | | | | | | | | | | | | | | | | | |
Net loss | | $ | (45,280 | ) | | $ | (1,387,915 | ) | | $ | - | | | | | $ | (1,433,195 | ) |
| | | | | | | | | | | | | | | | | | |
Net loss per common share - Basic and Diluted | | $ | (0.00 | ) | | $ | (0.14 | ) | | $ | - | | | | | $ | (0.10 | ) |
| | | | | | | | | | | | | | | | | | |
Weighted average number of common shares outstanding - Basic and Diluted | | | 55,058,006 | | | | 10,000,000 | | | | (51,387,223 | ) | | C, D | | | 13,670,773 | |
Omnia Wellness, Inc.
Pro Forma Combined Consolidated Statements of Operations
For the year ended December 31, 2019
(Unaudited)
| | Omnia Wellness, Inc | | | Omnia Wellness Corporation | | | Pro Forma Adjustments | | | Adj # | | Pro Forma Combined | |
| | | | | | | | | | | | | | |
Revenue | | | | | | | | | | | | | | | | | | |
Sales | | $ | - | | | $ | 223,354 | | | $ | - | | | | | $ | 223,354 | |
Total revenues | | | - | | | | 223,354 | | | | - | | | | | | 223,354 | |
| | | | | | | | | | | | | | | | | | |
Cost of goods sold | | | | | | | | | | | | | | | | | | |
Cost of goods sold | | | - | | | | 265,471 | | | | - | | | | | | 265,471 | |
Total cost of goods sold | | | - | | | | 265,471 | | | | - | | | | | | 265,471 | |
Gross loss | | | - | | | | (42,117 | ) | | | - | | | | | | (42,117 | ) |
| | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | |
Operating expenses | | | | | | | | | | | | | | | | | | |
Warranty expense | | | - | | | | 10,443 | | | | - | | | | | | 10,443 | |
Depreciation and amortization | | | - | | | | 191,287 | | | | - | | | | | | 191,287 | |
Legal and professional fees | | | - | | | | 106,645 | | | | - | | | | | | 106,645 | |
Selling and marketing expense | | | - | | | | 886,179 | | | | - | | | | | | 886,179 | |
Consulting fees | | | - | | | | 312,184 | | | | - | | | | | | 312,184 | |
General and administrative | | | 31,810 | | | | 58,346 | | | | - | | | | | | 90,156 | |
Impairment expense | | | - | | | | 26,000 | | | | - | | | | | | 26,000 | |
Total operating expenses | | | 31,810 | | | | 1,591,084 | | | | - | | | | | | 1,622,894 | |
| | | | | | | | | | | | | | | | | | |
Other expense | | | | | | | | | | | | | | | | | | |
Interest expense | | | - | | | | (293,766 | ) | | | - | | | | | | (293,766 | ) |
Total other expense | | | - | | | | (293,766 | ) | | | - | | | | | | (293,766 | ) |
| | | | | | | | | | | | | | | | | | |
Net loss | | $ | (31,810 | ) | | $ | (1,926,967 | ) | | $ | - | | | | | $ | (1,958,777 | ) |
| | | | | | | | | | | | | | | | | | |
Net loss per common share - Basic and Diluted | | $ | (0.00 | ) | | $ | (0.46 | ) | | $ | - | | | | | $ | (0.25 | ) |
| | | | | | | | | | | | | | | | | | |
Weighted average number of common shares outstanding - Basic and Diluted | | | 55,058,006 | | | | 4,181,781 | | | | (51,387,223 | ) | | C, D | | | 7,852,554 | |
Omnia Wellness, Inc.
Notes and Assumptions to Pro Forma Financial Statements
(Unaudited)
| (A) | On March 5, 2020, Omnia Wellness, Inc. completed a 12.63157 to 1 forward stock split whereby each share of common stock was converted into 12.63157 shares of common stock. |
| (B) | To adjust Omnia Wellness, Inc. shareholders’ equity (deficit) accounts to reflect the effects of the recapitalization, including 2,400,000 shares of existing Company stock (net of shares retired at date of the reverse merger) and the conversion of all outstanding shares of OWC into 10,000,000 common shares of Omnia Wellness, Inc. |
| (C) | To adjust Omnia Wellness, Inc. shareholders’ equity (deficit) accounts to reflect the conversion of the convertible promissory notes of OWC into 1,269,665 shares of Omnia Wellness, Inc. |
| (D) | To reflect the 12.63157 to 1 forward stock split of the Company as well as the retirement of shares related to the reverse merger. |
The unaudited pro forma combined financial statements do not include any adjustment for non-recurring costs incurred or to be incurred after September 30, 2020 by both the Company and OWC to consummate the Reverse Merger, except as noted above. Merger costs include fees payable for legal and accounting fees. Such costs will be expensed as incurred.